Lotte Krogh

941 total citations
15 papers, 179 citations indexed

About

Lotte Krogh is a scholar working on Cancer Research, Genetics and Molecular Biology. According to data from OpenAlex, Lotte Krogh has authored 15 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Lotte Krogh's work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Lipid metabolism and disorders (3 papers). Lotte Krogh is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Lipid metabolism and disorders (3 papers). Lotte Krogh collaborates with scholars based in Denmark, Sweden and Italy. Lotte Krogh's co-authors include M Castagneto, Ele Ferrannini, Antonio Gasbarrini, Henning Beck‐Nielsen, Amalia Gastaldelli, Geltrude Mingrone, Esmeralda Capristo, Antonio Greco, Thomas van Overeem Hansen and Anne‐Marie Gerdes and has published in prestigious journals such as PLoS ONE, Diabetes and Epilepsia.

In The Last Decade

Lotte Krogh

14 papers receiving 174 citations

Peers

Lotte Krogh
Lotte Krogh
Citations per year, relative to Lotte Krogh Lotte Krogh (= 1×) peers G Belsanti

Countries citing papers authored by Lotte Krogh

Since Specialization
Citations

This map shows the geographic impact of Lotte Krogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Krogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Krogh more than expected).

Fields of papers citing papers by Lotte Krogh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte Krogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Krogh. The network helps show where Lotte Krogh may publish in the future.

Co-authorship network of co-authors of Lotte Krogh

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Krogh. A scholar is included among the top collaborators of Lotte Krogh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Krogh. Lotte Krogh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Frederiksen, Jane Hübertz, Ulf Birkedal, Lene Juel Rasmussen, et al.. (2024). Reclassification of Two MLH1 Variants of Uncertain Significance Utilizing Clinical and Functional Data. Molecular Genetics & Genomic Medicine. 12(11). e70026–e70026.
2.
Hansen, Thomas van Overeem, Karin Wadt, Majbritt Busk Madsen, et al.. (2022). Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer. Human Genetics. 141(12). 1925–1933. 1 indexed citations
3.
Wadt, Karin, Uffe Birk Jensen, Charlotte Kvist Lautrup, et al.. (2019). Exploring the hereditary background of renal cancer in Denmark. PLoS ONE. 14(4). e0215725–e0215725. 13 indexed citations
4.
Tørring, Pernille Mathiesen, Martin J. Larsen, Charlotte Brasch‐Andersen, et al.. (2018). Is MED13L-related intellectual disability a recognizable syndrome?. European Journal of Medical Genetics. 62(2). 129–136. 21 indexed citations
5.
Nielsen, Henriette Roed, Janne Petersen, Lotte Krogh, Mef Nilbert, & Anne‐Bine Skytte. (2016). No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families. Familial Cancer. 15(4). 523–528. 2 indexed citations
6.
Krogh, Lotte, et al.. (2016). Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T). Current Genomics. 18(1). 93–103. 5 indexed citations
7.
Wadt, Karin, Lauren G. Aoude, Lotte Krogh, et al.. (2015). Molecular Characterization of Melanoma Cases in Denmark Suspected of Genetic Predisposition. PLoS ONE. 10(3). e0122662–e0122662. 18 indexed citations
8.
Wadt, Karin, et al.. (2014). [CDKN2A-mutation in a family with hereditary malignant melanoma].. PubMed. 176(40). 3 indexed citations
9.
Rasmussen, Lene Juel, Anne‐Marie Gerdes, Lotte Krogh, et al.. (2013). Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients. BMC Medical Genetics. 14(1). 103–103. 18 indexed citations
10.
Hansen, Thomas van Overeem, Lotte Krogh, Mari Korhonen, et al.. (2011). A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance—functional analysis reveals the pathogenic one. Familial Cancer. 10(3). 515–520. 2 indexed citations
11.
Krogh, Lotte, et al.. (2011). Improved prenatal detection of chromosomal anomalies.. PubMed. 58(8). A4293–A4293. 9 indexed citations
12.
Hansen, Lars, Anette Bygum, & Lotte Krogh. (2009). Infantile spasms and pigmentary mosaicism. Epilepsia. 51(7). 1317–1318. 3 indexed citations
13.
Mingrone, Geltrude, Antonio Greco, Lotte Krogh, et al.. (1999). Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.. Diabetes. 48(6). 1258–1263. 82 indexed citations
14.
Krogh, Lotte, et al.. (1997). 1.P.46 Detecting mutations in the lipoprotein lipase gene. Establishment and testing of a screening method. Atherosclerosis. 134(1-2). 26–26. 1 indexed citations
15.
Rohold, Allan, Lotte Krogh, Henry W. Nissen, et al.. (1997). 1.P.40 Lipoprotein lipase gene polymorphism and lipoprotein lipase activity in patients with previous acute myocardial infarction or non-insulin dependent diabetes mellitus. Atherosclerosis. 134(1-2). 25–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026